DaVita Corp (DVA) Price to Earnings Multiple

Corporate emblem and logo of DaVita Corp (DVA)

DaVita Inc. (DVA) maintains dominance in the outpatient dialysis sector, creating pricing power that supports the company's P/E ratio dynamics. The 12.60 metric determines this level, visualizing the efficiency of profit generation. The business relies on a niche kidney therapy market and government support. High barriers to entry and patients' lifelong need for procedures guarantee a predictable cash flow and the financial stability of the asset.

DVA: DaVita HealthCare Partners P/E Multiple 07/04/2022 - 11/15/2026

Analytical breakdowns for DaVita Inc. (DVA)

- market price and analyst price targets:
Summary company analysis:DaVita Inc.
Core merchandise of DaVita Corp

Stable demand for dialysis services provides DaVita Inc. (DVA) with exceptional cash flow predictability. By analyzing the company's P/E ratio dynamics, an investor can determine the current cost of a single unit of the business's net profit. This multiple defines the market premium for the asset by comparing total market capitalization with actual earnings. This allows for an assessment of the stock's margin of safety and the risk of correction should financial results deviate from expectations.

Competing companies

Market Cap to Earnings hcahealthcare.com HCA|Price to Earnings Ratio Tenet Healthcare (THC)|Fresenius Medical Care - Price to Earnings Multiple|Price to Earnings Ratio Solventum SOLV|Market Price to Net Income Ratio EHC (Encompass Health)|UHS: Price to Earnings Ratio|RadNet Inc - Market Price to Net Income Ratio|optioncarehealth.com (OPCH) - Price to Earnings Ratio|SGRY - Business Payback Period|Price to Earnings Ratio Premier, Inc.|EYE (National Vision Holdings) - Market Price to Net Income Ratio|Price to Earnings Ratio Progyny Corp (PGNY)|Ardent Health Partners - Price to Earnings Multiple|P/E Multiple SEM (Select Medical Inc.)|Company Value to Net Income ASTH|MD - Price to Earnings Ratio|Company Value to Net Income USPH (U.S. Physical Therapy, Inc.)|PNTG: P/E Multiple|Market Cap to Earnings Organogenesis (ORGO)|NUTX (Nutex Health Corp) - P/E Multiple|P/E Multiple Auna Health|P/E Multiple SBC|Business Payback Period evolus.com|Community Health Systems, Inc. - Price to Earnings Ratio|Market Price to Net Income Ratio SKIN (beautyhealth.com)|MDWD: Price to Earnings Ratio|Market Cap to Net Income BTMD|JYNT: P/E Multiple|Price to Earnings Multiple DCGO|PIII (P3 Health Partners Inc.) - P/E Multiple|Market Cap to Earnings Gain Therapeutics, Inc. GANX|Price to Earnings Ratio EUDA (EUDA Health Holdings)|Price to Earnings Ratio BMGL (Basel Medical Group Limited)|CollPlant Biotechnologies Ltd. - Price to Earnings Ratio|CUPR: Price to Earnings Multiple|CCM: Price to Earnings Ratio|Company Value to Net Income AMS (American Shared Hospital Services)|MRM: P/E Multiple|Market Cap to Earnings Avalon GloboCare Corp (ALBT)|Price to Earnings Ratio DIH Holding|XAGE: Company Value to Net Income|P/E Multiple NIVF|P/E Multiple ATI Physical Therapy Inc. (ATIP)|P/E Multiple CMAX (caremax.com)|Market Price to Net Income Ratio KDLY (Kindly Health)|MODV - Price to Earnings Ratio|Market Cap to Earnings novointegrated.com|SunLink Health Systems (SSY) - Price to Earnings Ratio|Price to Earnings Ratio IMAC Holdings Inc